✦ LIBER ✦

Anti-Müllerian hormone: A marker for ovarian function in systemic lupus erythematosus patients treated with cyclophosphamide

✍ Scribed by Ghaleb, Rasha M.; Fahmy, Khaled A.

Book ID: 122470640
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 107 KB
Volume: 80
Category: Article
ISSN: 1297-319X
DOI: 10.1016/j.jbspin.2012.10.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-müllerian hormone and ovarian reser

Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus

✍ Mok, C. C.; Chan, P. T.; To, C. H. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Assessment of ovarian function with anti

Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant

✍ Hyacinth Browne; Alicia Armstrong; Alan DeCherney; Rebecca Babb; Gabor Illei; Ja 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Ovarian failure in systemic lupus erythe

Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide

✍ Katsifis, G. E. (author);Tzioufas, A. G. (author) 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 242 KB

Ovarian failure in systemic lupus erythe

Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide

✍ Katsifis, G. E. (author);Tzioufas, A. G. (author) 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 242 KB

Cyclophosphamide (CYC) exposure in pedia

Cyclophosphamide (CYC) exposure in pediatric patients with systemic lupus erythematosus (pSLE) is associated with reduced serum anti-mullerian hormone (AMH) levels

✍ L.C. Grossman; J. Isgro; S.K. Nurudeen; M.V. Sauer; R. Lobo; N.C. Douglas 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Risk factors for ovarian failure in pati

Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

✍ Chi Chiu Mok; Chak Sing Lau; Raymond Woon Sing Wong 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

## Objective: To determine the incidence of ovarian failure after cyclophosphamide (cyc) treatment for systemic lupus erythematosus (sle) and to identify the risk factors for this complication. ## Methods: The records of 70 premenopausal female sle patients treated with cyc were reviewed retrospe